Yanghuang Zheng

Mr. Yanghuang Zheng


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2024 in Cancer Medicine
Verified
Journal Article
Open access
YZYanghuang Zheng
Yanghuang Zheng
HSHongjin Shi
Hongjin Shi
SFShi Fu
Shi Fu
HWHaifeng Wang
Haifeng Wang
JWJincheng Wang
Jincheng Wang
JZJinsong Zhang
Jinsong Zhang
Objectives: Development and validation of a computed tomography urography (CTU)‐based machine learning (ML) model for prediction of preoperative pathology grade of upper urinary tract urothelial carcinoma (UTUC).Methods: A total of 140 patients with UTUC who underwent CTU examination from January 2017 to August 2023 were retrospectively enrolled. Tumor lesions on the unenhanced, medullary, and excretory periods of CTU were used to extract Features, respectively. Feature selection was screened by the Pearson and Spearman correlation analysis, least absolute shrinkage and selection operator algorithm, random forest (RF), support vector machine (SVM), and eXtreme Gradient Boosting (XGBoost). The logistic regression (LR) was used to screen for independent influencing factors of clinical baseline characteristics. Machine learning models based on different feature datasets were constructed and validated using algorithms such as LR, RF, SVM, and XGBoost. By computing the selected features, a radiomics score was generated, and a diverse feature dataset was constructed. Based on the training set, 16 ML models were created, and their performance was evaluated using the validation set for metrics including sensitivity, specificity, accuracy, area under the receiver operating characteristic curve (AUC), and others.Results: The training set consisted of 98 patients (mean age: 64.5 ± 10.5 years; 30 males), whereas the validation set consisted of 42 patients (mean age: 65.3 ± 9.78 years; 17 males). Hydronephrosis was the best independent influence factor (p < 0.05). The RF model had the best performance in predicting high‐grade UTUC, with AUC of 0.914 (95% Confidence Interval [95%CI] 0.852–0.977) and 0.903 (95%CI 0.809–0.997) in the training set and validation set, and accuracy of 0.878 and 0.857, respectively.Conclusions: An ML model based on the RF algorithm exhibits excellent predictive performance, offering a non‐invasive approach for predicting preoperative high‐grade UTUC.

3 May 2024 in International Journal of Surgery
Verified
Journal Article
Open access
YZYanghuang Zheng
Yanghuang Zheng
JSJin Hong Shi
Jin Hong Shi
BHBin Hai
Bin Hai
JZJinsong Zhang
Jinsong Zhang
An abstract is unavailable. This article is available as a PDF only.

23 February 2024 in Medicine
Verified
Journal Article
Open access
YZYanghuang Zheng
Yanghuang Zheng
HSHongjin Shi
Hongjin Shi
HWHaifeng Wang
Haifeng Wang
JWJiansong Wang
Jiansong Wang
BHBin Hai
Bin Hai
JZJinsong Zhang
Jinsong Zhang
Rationale: Melanoma is one of a common cutaneous malignancy. Currently, metastatic malignant melanoma is difficult to be diagnosed through imaging examinations. Furthermore, the incidence of metastatic melanoma affecting the gallbladder and ureter is exceptionally rare. Patient concerns: A 54-year-old female was admitted to the hospital with a half-month history of left lower back pain. Correlative examination revealed an occupying lesion in the mid-left ureter and the neck of the gallbladder. Diagnoses: The patient was initially diagnosed with gallbladder cancer and left ureteral carcinoma based on imaging. Following 2 operations, immunohistochemical staining confirmed the presence of metastatic melanoma involving both the gallbladder and ureter. Intervention: After multidisciplinary consultation and obtaining consent from the patient and her family, the patient underwent left radical nephroureterectomy, radical cholecystectomy, laparoscopic partial hepatectomy (Hep IV, Hep V), and lymph node dissection of hepatoduodenal ligament. Outcomes: One month after treatment, the patient imaging showed no disease progression, and at 6 months of follow-up, the patient was still alive. Lessons: It is difficult to distinguish metastatic melanoma from carcinoma in situ by imaging. In addition, metastatic malignant melanoma lacks specific clinical manifestations and is prone to misdiagnosis, which emphasizes the highly aggressive nature of malignant melanoma.